Architect HIV

Device Abbott Laboratories
Total Payments
$1.4M
Transactions
30
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2021 $275,000 1 0
2019 $437,831 6 1
2018 $5,234 18 4
2017 $643,831 5 2

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.3M 5 92.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $95,570 3 7.0%
Consulting Fee $1,500 1 0.1%
Travel and Lodging $1,498 7 0.1%
Food and Beverage $858.21 14 0.1%

Payments by Type

Research
$1.3M
5 transactions
General
$99,427
25 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Novel Viruses Associated with Human Diseases Abbott Laboratories $825,000 0
Sponsored Research Agreement #3 with University of California San Francisco Abbott Laboratories $412,500 0
Exploring Viral Strain Diversity in the Democratic Republic of Congo Abbott Laboratories $24,970 0

Top Doctors Receiving Payments for Architect HIV

Doctor Specialty Location Total Records
Unknown Columbia, MO $1.4M 10
, M.D., PH.D Infectious Disease San Francisco, CA $5,002 14
, M.D Internal Medicine Cincinnati, OH $1,500 1
Dennis Israelski Infectious Disease Redwood City, CA $118.76 1
, M.D., PH.D Clinical Pathology/Laboratory Medicine San Francisco, CA $97.03 1
, DO Emergency Medical Services Phoenixville, PA $23.26 1
, MD Hospitalist Indianapolis, IN $17.02 1
, D.O Infectious Disease Anderson, SC $11.42 1

About Architect HIV

Architect HIV is a device associated with $1.4M in payments to 7 healthcare providers, recorded across 30 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.

Payment data is available from 2017 to 2021. In 2021, $275,000 was paid across 1 transactions to 0 doctors.

The most common payment nature for Architect HIV is "Unspecified" ($1.3M, 92.7% of total).

Architect HIV is associated with 3 research studies, including "Novel Viruses Associated with Human Diseases" ($825,000).